Bio

Bio


Addie Peretz, MD, is a board certified Neurologist and a Clinical Assistant Professor of Neurology & Neurological Sciences.
Her clinical interests focus on the diagnosis and treatment of headache and facial pain conditions. She is involved in medical education, and received the Robert S. Fisher Teaching Award for excellence in Neurology resident teaching of Stanford medical students. Her research interests include understanding the biological underpinnings of migraine and chronic daily headaches. She also participates in clinical trials of new headache treatments.

Clinical Focus


  • Neurology
  • Headache Medicine

Academic Appointments


Honors & Awards


  • Robert S. Fisher Teaching Award, Stanford Neurology Residency Program (2014)
  • Pediatric Narrative Award, New York University School of Medicine (2009)
  • Magna Cum Laude, Brown University (2007)

Boards, Advisory Committees, Professional Organizations


  • Member, American Headache Society (2015 - Present)
  • Member, International Headache Society (2015 - Present)

Professional Education


  • Medical Education:New York University School of Medicine (2011) NY
  • Internship:Medstar Georgetown University Hospital GME Training Verifications (2012) DC
  • Residency, Stanford Healthcare, Neurology Residency (2015)
  • Fellowship, Stanford Healthcare, Headache & Facial Pain Fellowship (2016)
  • Board Certification: Neurology, American Board of Psychiatry and Neurology (2015)
  • Board Certification: Headache Medicine, United Council for Neurologic Subspecialties

Research & Scholarship

Current Research and Scholarly Interests


Dr. Peretz's research interests include understanding the biological underpinnings of migraine and chronic daily headaches. She also participates in clinical trials of new headache treatments.

Publications

All Publications


  • Exploring Natural Cohorts of Chronic Migraine Phenotype Woldeamanuel, Y., Sanjanwala, B., Peretz, A., Cowan, R. LIPPINCOTT WILLIAMS & WILKINS. 2019
  • Altered structural brain network topology in chronic migraine. Brain structure & function DeSouza, D. D., Woldeamanuel, Y. W., Sanjanwala, B. M., Bissell, D. A., Bishop, J. H., Peretz, A., Cowan, R. P. 2019

    Abstract

    Despite its prevalence and high disease burden, the pathophysiological mechanisms underlying chronic migraine (CM) are not well understood. As CM is a complex disorder associated with a range of sensory, cognitive, and affective comorbidities, examining structural network disruption may provide additional insights into CM symptomology beyond studies of focal brain regions. Here, we compared structural interconnections in patients with CM (n?=?52) and healthy controls (HC) (n?=?48) using MRI measures of cortical thickness and subcortical volume combined with graph theoretical network analyses. The analysis focused on both local (nodal) and global measures of topology to examine network integration, efficiency, centrality, and segregation. Our results indicated that patients with CM had altered global network properties that were characterized as less integrated and efficient (lower global and local efficiency) and more highly segregated (higher transitivity). Patients also demonstrated aberrant local network topology that was less integrated (higher path length), less central (lower closeness centrality), less efficient (lower local efficiency) and less segregated (lower clustering). These network differences not only were most prominent in the limbic and insular cortices but also occurred in frontal, temporal, and brainstem regions, and occurred in the absence of group differences in focal brain regions. Taken together, examining structural correlations between brain areas may be a more sensitive means to detect altered brain structure and understand CM symptomology at the network level. These findings contribute to an increased understanding of structural connectivity in CM and provide a novel approach to potentially track and predict the progression of migraine disorders.This study is registered on ClinicalTrials.gov (Identifier: NCT03304886).

    View details for DOI 10.1007/s00429-019-01994-7

    View details for PubMedID 31792696

  • Migraine Action Plan (MAP). Headache Peretz, A. M., Minen, M. T., Cowan, R., Strauss, L. D. 2018; 58 (2): 355?56

    View details for PubMedID 29411363

  • Introducing the Migraine Action Plan HEADACHE Peretz, A. M., Minen, M. T., Cowan, R., Strauss, L. D. 2018; 58 (2): 195

    View details for PubMedID 29411373

  • Interactions between affective measures and amygdala volume in chronic migraine: associations in the absence of group volumetric differences Desouza, D. D., Woldeamanuel, Y. W., Peretz, A. M., Sanjanwala, B. M., Cowan, R. P. SAGE PUBLICATIONS LTD. 2017: 47?48
  • Validating a Screening Tool for Chronic Migraine Hindiyeh, N., Shahin, M., Zhang, N., Peretz, A., von Eyben, R., Cowan, R., Aurora, S. WILEY-BLACKWELL. 2016: 1397?98
  • A study of adverse events attributed to Onabotulinum Toxin A for Chronic Migraine Prophylaxis Peretz, A., Zhang, N., Hindiyeh, N., Aurora, S. WILEY-BLACKWELL. 2016: 25?26
  • Utah Aura Project, Investigating the Association between Migraine Aura and Altitude Ahmed, Z. A., Digre, K., Brennan, K., Aurora, S., Peretz, A., Baggaley, S. WILEY-BLACKWELL. 2016: 43?44
  • Sudden Onset of Slurring of Speech Case-Based Neurology Peretz, A., Singh, A. Demos Medical. 2011; 1
  • Subclinical Hypothyroidism: To Screen or Not to Screen? Peretz, A. NYU Langone Online Journal of Medicine. 2011 ; Clinical Correlations
  • Headache and Loss of Consciousness Case-Based Neurology Kurzweil, A., Peretz, A., Singh, A. Demos Medical. 2011; 1

Footer Links:

Stanford Medicine Resources: